Adaptam Therapeutics raised a €3 million pre-seed financing round led by Criteria Bio Ventures.
13 October 2025
13 October 2025
Total investments received (USD): 3.52M
Round value (USD): 3.52M
Round investors: Caixa Capital Risc
Company: Adaptam Therapeutics
Industry: BiotechHealth services
Related deals
Atlas Molecular Pharma closed a €3 million deal led by Inveready, joined by CDTI, Grupo SPRI, Kereon Partners, Endometrial DIDI, and CRB Inverbio
Investments
04 January 2026
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
United Kingdom